Skip to main content
Medicare × Transplant and immunosuppressant

How to appeal a Medicare (Original + Advantage) transplant and immunosuppressant denial

Solid-organ transplant patients depend on continuous immunosuppressive therapy to prevent rejection. This guide is specific to Medicare (Original + Advantage) appeals.

Why Medicare (Original + Advantage) denies transplant and immunosuppressant

Medicare is a federal program with two delivery modes — Original (fee-for-service Part A/B + Part D drug plans) and Advantage (private MA-C plans). Each has its own appeal ladder, and rights are stronger than most beneficiaries realize.

For transplant and immunosuppressant specifically: Solid-organ transplant patients depend on continuous immunosuppressive therapy to prevent rejection. UNOS/OPTN guidelines establish that immunosuppressant regimens generally cannot be switched without significant clinical risk. Denials of transplant evaluation, listing, surgery, or maintenance immunosuppression are among the most clinically urgent appeals.

The Medicare (Original + Advantage) appeal process

Appeal levels: 5 federal levels. Each has its own deadline and a minimum dollar threshold for the higher levels (ALJ requires $190+ in 2026).

Timing: 120 days from denial for level 1 (Original) or 60 days for Medicare Advantage. Each subsequent level: 60 days.

What we know about Medicare (Original + Advantage): Medicare cases require a CMS-1696 Appointment of Representative form for us to act on your behalf. We provide this at intake.

Common Medicare (Original + Advantage) denial patterns for transplant and immunosuppressant

  • Original Medicare: 5-level appeal. Redetermination by MAC → reconsideration by QIC → ALJ hearing → Medicare Appeals Council → federal district court. The QIC and ALJ levels reverse a substantial share of denials when properly briefed.
  • Medicare Advantage: identical 5-level ladder. MA plans must follow the same federal appeal structure as Original Medicare. Plan-level reconsideration → Independent Review Entity (Maximus) → ALJ → Council → federal court.
  • Part D drug coverage denials. Part D appeals follow a separate but parallel ladder. Tiering exceptions and formulary exceptions are filed before a coverage determination challenge.

The reversal pathway for transplant and immunosuppressant appeals

Successful transplant and immunosuppressant appeals against Medicare (Original + Advantage) typically require:

  1. Procedural-rights anchor. Every Medicare (Original + Advantage) denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter must invoke these in the opening paragraph to lock the timeline and force criteria disclosure.
  2. Criteria-disclosure demand. Medicare (Original + Advantage) (like all major insurers) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Federal law requires they disclose on request — and once they do, the criteria become the rebuttal map.
  3. Treating-provider attestation. A letter from the treating physician explaining medical necessity in the specific terms the carrier's policy uses. This is the single strongest evidentiary element.
  4. Peer-reviewed citations. At least two journal citations (NEJM, JAMA, Lancet, etc.) or specialty-society guidelines (NCCN, AASM, ACR Appropriateness Criteria) supporting the requested service for the patient's clinical profile.
  5. Plan-language anchor. The specific policy section that controls the determination, quoted verbatim with policy section number.
  6. Requested action. Clear, specific request for reversal — not a general "please reconsider."

What Apellica does for Medicare (Original + Advantage) transplant and immunosuppressant appeals

We file appeals against Medicare (Original + Advantage) specifically configured to its internal review process. Every appeal includes the criteria-disclosure demand, the procedural-rights anchor, treating-provider attestation language, and the specific peer-reviewed citations relevant to the denied service.

Cost: $0 upfront. We work on contingency for Medicare (Original + Advantage) appeals — if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your Medicare (Original + Advantage) transplant and immunosuppressant appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

Related Medicare (Original + Advantage) guides

Other carriers — transplant and immunosuppressant denials guides

Start Free Case Review